Worth the Wait Awarded Grant from Takeda Pharmaceuticals U.S.A., Inc..

Worth the Wait Awarded Grant from Takeda

Worth the Wait is a 2023 recipient of Takeda’s Improving Health Equity in Cancer: A Community Grant Program. The grants were provided to patient advocacy organizations that are helping to address the needs of medically underserved people with cancer through community-based initiatives.

 

“We’re honored to have Takeda’s support. Worth the Wait will use the funds to help young cancer survivors in Ohio who are preserving fertility or starting families in survivorship,” shared Worth the Wait Co-Founder Megan Scherer.